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Abstract
Surfactant protein D (SP-D) is considered to play an important role in innate immunity in the lungs by binding, via its
multiple C-type lectin domains, to carbohydrate structures present on a range of viruses, bacteria, yeasts and fungi. The
resulting agglutination of the target pathogens provides host defence which can be further enhanced by killing and clearance
mechanisms mediated by phagocytic cells which carry receptors for SP-D. Recent findings suggest that SP-D, and the
structurally related lung surfactant protein A (SP-A), may also modulate allergic reactions by binding certain glycosylated
allergens. The finding of SP-D at a variety of other sites besides the lungs, such as the gastric mucosae, is suggestive that it
may play a general protective role in several secretions. ß 1998 Elsevier Science B.V. All rights reserved.
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1. Introduction
The four well-characterised lung surfactant pro-
teins SP-A, SP-B, SP-C and SP-D appear to play
quite di¡erent roles in the lung. SP-B and SP-C are
hydrophobic polypeptides which are intimately asso-
ciated with the lipid bilayer and are essential for full
lung function via their property of accelerating the
adsorption of lipids to the air-liquid interface. SP-A
and SP-D are, in comparison to SP-B and SP-C,
relatively hydrophilic and are members of the ‘collec-
tin’ group of C-type lectins which include the serum
proteins mannose binding lectin, conglutinin and col-
lectin-43 [1]. The collectins are characterised by their
having polypeptide chains containing a short (7^28
amino acids), cysteine-rich, N-terminal section fol-
lowed by a collagen-like region (59^171 amino
acids), then an K-helical section of approximately
37 amino acids and a C-terminal, C-type lectin do-
main (of about 120 amino acids). In SP-D three iden-
tical 43 kDa polypeptide chains form a 140 kDa
trimeric subunit which contains a collagen-like triple
helix (over the 171 residues of collagen-like sequence)
and an K-helical coiled-coil (over the 37 residues of
the K-helical section). Four of the trimeric subunits
are linked via their N-terminal sections to yield a
tetrameric 560 kDa molecule with 12 C-type lectin
domains which can all potentially bind to arrays of
carbohydrates of the type that can be found on the
surfaces of certain lung pathogens. It is well-estab-
lished that the serum collectins play an important
role in innate immunity, via their carbohydrate rec-
ognition properties, and it has become clear, over
approximately the past 5 years, that both SP-A and
SP-D are also probably involved in host defence
mechanisms. More extensive discussion on the struc-
ture and expression of SP-D is given in the article by
E.C. Crouch [2] in this special issue of Biochimica
Biophysica Acta. In the case of SP-A, although it is
strongly associated with the surfactant lipids and has
been proposed to play a role in surfactant homeo-
stasis, it has been found that genetically engineered
SP-A-de¢cient mice have essentially normal lung
structure and function but are more susceptible to
lung infections [3] and this area of research is more
fully covered in the article by Korfhagen et al. [4]
which is also presented in this special issue. There
is a growing body of evidence which indicates that
the primary role of SP-D in the lung is to combat
infection and the production of genetically engi-
neered SP-D-de¢cient mice should allow a full assess-
ment of this point.
2. Interactions of surfactant protein SP-D with
pathogens
It is well established that SP-D binds, in a calcium-
dependent manner, to carbohydrate structures on the
surfaces of a wide range of pathogens resulting in
agglutination of the target organisms. The pathogens
recognised and, in most cases, agglutinated by SP-D
include Gram-negative bacteria [5], viruses [6], yeasts
[7] and fungi [8].
The carbohydrate structures, on these pathogens,
which are recognised by SP-D are in most cases not
well characterised. However, in the case of SP-D
interaction with Gram-negative bacteria the binding
seems likely to be mediated between the C-type lec-
tin domains of SP-D and the core sugars of the
bacterial capsular lipopolysaccharides [5,9]. The
strong inactivation by SP-D, of red blood cell hae-
magglutination activity of various strains of in£uen-
za A viruses, appears to result from the binding of
the C-type lectin domains of the SP-D to carbohy-
drate structures on the head region of the virus hae-
magglutinin [6]. This view is supported by a report
showing that the degree of glycosylation of a virus is
an important factor in its virulence and also in the
ability of SP-D to inhibit viral infection [10]. The
structure recognised by SP-D when it binds and ag-
glutinates the acapsular form of the yeast pathogen
Cryptococcus neoformans is not known, but it is clear
that the encapsulated form of the yeast is not recog-
nised by SP-D and therefore the 1,3-mannose back-
bone and xylosyl and glucuronosyl side chains of the
polysaccharide are not bound by SP-D [7]. The tar-
get for SP-D on the fungus Pneumocystis carinii is a
heavily glycosylated 95^120 kDa cell surface mole-
cule, the major surface antigen on the organism,
which is rich in mannose, glucose and N-acetylglu-
cosamine [11]. In the agglutination of the fungus
Aspergillus fumigatus by SP-D it is not known ex-
actly which structures are the binding sites for SP-D
on the fungal conidia, but it has been established
that SP-D binds strongly to two of the major anti-
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gens, the glycoproteins gp45 and gp55, secreted by
the fungus [12].
The recent ¢nding [13] of exceptionally low levels
of SP-D, and SP-A, in the bronchoalveolar lavage of
children with cystic ¢brosis may be very relevant to
the fact that these patients are very susceptible to
infection by a range of organisms, notably Staphylo-
coccus aureus, Haemophilus in£uenza and Pseudomo-
nas aeruginosa. However, it is not absolutely clear yet
whether the low levels of SP-D and SP-A are
brought about by a state of chronic infection in older
children or whether there is a fundamental de¢ciency
of SP-D and SP-A function in newly born children
with cystic ¢brosis which exposes them to infection.
However, there is some evidence supporting the view
that the low levels of SP-A may be related to chronic
infection. This emerged from a study where very
young children with cystic ¢brosis, who had been
identi¢ed by a neonatal screening programme, were
examined and it was found that those with lung in-
fections had increased SP-A levels in their bronchoal-
veolar lavage samples [14].
3. Cell surface receptors for SP-D
SP-A and other collectins such as serum MBL, but
not SP-D, have been shown to bind to the wide-
spread cC1qR/collectin ‘receptor’ [15] which now ap-
pears to be generally accepted as being a membrane-
associated form of the intracellular, calcium-binding
protein called calreticulin [16]. The binding of C1q,
SP-A and MBL, but again not SP-D, to another
molecule de¢ned as a C1q receptor, the C1qRp
present on cells of myeloid origin, platelets and en-
dothelial cells, has also been demonstrated [17]. It
does therefore appear unlikely that SP-D binds to
cells via proteins which are known to show a⁄nity
for C1q and this is consistent with the demonstra-
tion that the speci¢c binding of labelled SP-D to
alveolar macrophages could be inhibited by unla-
belled SP-D but not by C1q [18]. Assessment of
the binding of SP-D to alveolar macrophages is com-
plicated by the observation in one study that it
bound speci¢cally to the cells in a calcium-independ-
ent manner [18] yet in another study the binding was
found to be calcium-dependent and inhibitable by
saccharides [19]. In the study, where calcium-inde-
pendent binding was seen, human SP-D and human
alveolar macrophages were used whereas the other
study, showing calcium-independent binding, used
rat alveolar macrophages. It is possible that alveolar
macrophages may even express three distinct types
of binding protein/receptor for SP-D since the puta-
tive receptor, designated glycoprotein-340 (gp-340)
has recently been characterised [20] and it appears
to bind SP-D in calcium-dependent manner which is
not inhibitable by saccharides. The gp-340 was iso-
lated as soluble protein from lung lavage obtained
from several alveolar proteinosis patients. It is com-
posed of polypeptide chains of 340 kDa, when ex-
amined on SDS-PAGE under reducing conditions,
and partial amino acid sequence showed that it is
a new member of the scavenger-receptor cysteine-
rich superfamily containing multiple scavenger re-
ceptor type B domains. The soluble form of gp-340
has an apparent molecular mass of approximately
1000 kDa in non-dissociating conditions and immu-
nohistochemical analysis, using both polyclonal and
monoclonal antibodies, has shown it to be present
on the surface and within alveolar macrophages [20].
Although some partial cDNA data are now available
it is still not known how the surface form of gp-340
is anchored in the membrane. It is possible that gp-
340 is found as alternatively spliced soluble and
membrane forms as has been described, in the
mouse, for a closely related member of this scav-
enger-receptor family of molecules [21]. It has been
shown that there is direct binding between gp-340
and puri¢ed native SP-D at physiological ionic
strength and that the binding is dependent upon
the presence of calcium but cannot be inhibited by
maltose [20]. Similar binding is seen between gp-340
and a recombinant fragment of SP-D, composed of
the trimeric K-helical neck region and three carbohy-
drate recognition domains. Although the interaction
between gp-340 and SP-D involves the carbohydrate
recognition domains of SP-D, the inability of mal-
tose to block the interaction indicates that the bind-
ing between gp-340 and SP-D is not dependent upon
the recognition of carbohydrate structures. Thus, gp-
340 may represent one type of receptor for SP-D on
alveolar macrophages but, as judged from the bind-
ing experiments described at the beginning of this
section, there may be at least two other types still
to be characterised.
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4. Biological e¡ects triggered by binding of SP-D to
pathogens and to cells
SP-D has been shown to be a strong chemoattrac-
tant for both monocytes and neutrophils [22,8]. Since
the chemotactic e¡ect can be blocked by saccharides,
or the addition of antibodies raised against the
C-type lectin domains of SP-D, it is probable that
the chemotactic e¡ects are mediated by the C-type
lectin domains of SP-D binding to cell-surface car-
bohydrate structures. SP-D has also been shown to
enhance the production of oxygen radicals by alveo-
lar macrophages and neutrophils [23,8]. An increased
release of oxygen radicals from neutrophils was seen
on the binding of SP-D to the conidia of Aspergillus
fumigatus [8]. There is, at present, little evidence to
show that binding and agglutination of pathogenic
microorganisms by SP-D leads to increased phago-
cytosis of the pathogens. For example, although it
was shown that SP-D enhanced the binding of Pneu-
mocystis carinii to alveolar macrophages, in a rat
model of infection, this did not enhance the uptake
of the microorganism by the cells [11]. However, in-
creased killing and phagocytosis of the conidia of
Aspergillus fumigatus by neutrophils, on the addition
of SP-D, has been reported [8].
5. Interactions of surfactant proteins SP-A and SP-D
with allergens
The concept that SP-A and SP-D might play a role
in the modulation of allergic responses stems from an
observation in 1993 that SP-A binds to a variety of
pollens which are common allergens, these included
pollen from Lombardy poplar, Kentucky blue grass,
cultivated rye and short ragweed [24]. In this study
the SP-A was shown to bind to the major 57 kDa
and 7 kDa proteins present in a water extract of
Lombardy poplar pollen, and the results presented
were consistent with the view that the interaction
took place between the C-type lectin domains and
carbohydrate structures on the pollen proteins. The
binding of SP-A to the pollen grains allowed adhe-
sion of the grains to the A549 cell line derived from
alveolar type II cells. The possible involvement of
SP-D, as well as SP-A, in allergen binding was ex-
amined in a study [25] involving allergens present in
the faecal pellets of the house dust mite (Dermato-
phagoides pteronyssinus, Der p). The house dust mite
is a major source of inhaled allergens, many of which
are proteinases. Allergen-speci¢c IgE antibody re-
sponses are seen against three major allergens (Der
p I, II and III) as well as several minor allergens in
allergic patients. It was found that both SP-A, and
SP-D, bound to whole mite extract and puri¢ed na-
tive Der p I in a carbohydrate speci¢c and calcium-
dependent manner [25]. Furthermore both SP-A and
SP-D were shown to inhibit allergen-speci¢c IgE
from binding to whole mite extract. This inhibition
of binding appears to be functionally signi¢cant since
it has recently been found that SP-A and SP-D can
inhibit histamine release in an assay in which samples
of diluted whole blood of asthmatic children were
challenged with Der p allergen in the presence of
surfactant proteins [26]. In the same study [26]
SP-A and SP-D were shown to reduce the incorpo-
ration of [3H]thymidine into peripheral blood mono-
nuclear cells which had been isolated from asthmatic
children and then stimulated with Der p extract or
phytohaemagglutinin p. It therefore appears that SP-
A and SP-D may modulate the development of asth-
matic symptoms by both inhibiting histamine release
in the early phase of allergen challenge and suppress-
ing lymphocyte proliferation in the later states of
asthmatic attacks where there is bronchial in£amma-
tion. These inhibitory e¡ects, shown by SP-A and
SP-D, against Der p allergen-mediated reactions
may prove to be a general defence role which the
lung surfactant proteins play against a range of gly-
cosylated allergens. Support of this view is provided
by the ¢nding that SP-A and SP-D can inhibit spe-
ci¢c IgE binding to the allergens of the fungus As-
pergillus fumigatus and also block allergen-induced
histamine release from allergic patients’ basophils
[12].
6. Evidence for the presence of SP-D at other sites in
the body besides the lungs
SP-D is predominately localised in the lung, where
it is synthesised by type II alveolar cells and Clara
cells, but there is now convincing evidence that it is
also synthesised and secreted at a variety of other
sites in the body. The ¢nding, by Northern blotting,
BBADIS 61778 2-11-98
K.B.M. Reid / Biochimica et Biophysica Acta 1408 (1998) 290^295 293
of a 1.5 kb signal for human SP-D RNA in samples
from small intestine, colon, heart and pancreas, as
well as lung [27], is consistent with the reports of
mRNA for SP-D in the gastric mucosa of the rat
[28], mouse heart, stomach and kidney [29] and mes-
entery cells in rat and man [30]. There is also good
immunochemical evidence that SP-D protein is pro-
duced in the gastric mucosa in the rat [28] and also in
human salivary, sweat, mammary and tear glands
[31].
The ¢nding of SP-A expression by epithelial cells
of both the large and small intestine of the rat [32],
and the presence of SP-A in human colon [33], sug-
gests that SP-A, like SP-D, may also ful¢l a role in
innate immunity at other sites besides the lungs.
7. Expression of a recombinant fragment of SP-D for
possible therapeutic use
A recombinant fragment of human SP-D, which is
composed of the K-helical neck region and three C-
type lectin domains, has been produced in Escheirch-
ia coli and in the yeast Pichia pastoris. The approx-
imately 60 kDa trimeric structure, which is held to-
gether by strong hydrophobic forces within the neck
region of SP-D [34], has been shown to bind, in the
same fashion as intact SP-D, to the lipopolysacchar-
ides of several strains of Gram-negative bacteria
known to cause lung infections [9]. This recombinant
material has also been shown to be e¡ective in block-
ing the interactions of glycosylated allergens with
speci¢c IgE [25,26]. The e¡ectiveness of the recombi-
nant trimeric neck-C-type lectin structure, derived
from SP-D, in combating lung infection and aller-
gen-mediated reactions is currently being tested in
mouse models.
8. Conclusion
SP-D and SP-A appear to play important roles in
innate immunity in the lung surfactant and perhaps
at a number of other sites in the body. The recogni-
tion of pathogens by SP-D involves the binding of its
trimeric clusters of carbohydrate recognition do-
mains to arrays of complex carbohydrates on the
surfaces of the target microorganisms. This action
may simply agglutinate and neutralise the microor-
ganisms but the reports of at least two types of spe-
ci¢c receptors for SP-D on phagocytic cells is consis-
tent with the view that triggering of cell-surface
receptors by SP-D enhances the killing and clearance
of lung pathogens.
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